1-18 of 18
Amy Dezern, MD, MHS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Battle of the Clones: Somatic Genetic Rescue of Pediatric Patients With MDS Teaches Us About MDS Biology in 2021 and a Platform for the Future

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2022) 19 (1)
https://doi.org/10.1182/hem.V19.1.202214
Published: 2022
Articles

Older Patients With High-Risk MDS Benefit From Allogeneic Stem Cell Transplantation

Free
Michael J. Hochman, MD, Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2021) 18 (6)
https://doi.org/10.1182/hem.V18.6.202161
Published: 2021
Articles

Release More Inhibitions? Pegcetacoplan Treatment for Patients With Paroxysmal Nocturnal Hemoglobinuria

Free
Gloria F. Gerber, MD, Amy Dezern, MD, MHS
Journal: The Hematologist
The Hematologist (2021) 18 (5)
https://doi.org/10.1182/hem.V18.5.202151
Published: 2021
Articles

Can We “Go with the Flow?”

Free
Amanda B. Kagan, MD, Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2021) 18 (3)
Published: 2021
Articles

Short-term Gain But Long-term Pain? Clonal Hematopoiesis and the Risk of Therapy-related Myeloid Neoplasms After Treatment for Solid Tumors

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2021) 18 (2)
Published: 2021
Articles

Big Questions in 2020: Single-cell Sequencing in Myeloid Malignancies Brings Us Closer to Answers

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2020) 18 (1)
Published: 2020
Articles

Safe Tension: What the Latest Data Say About Waiting to Induce in AML

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2020) 17 (6)
Published: 2020
Articles

Variant CURation: A Key Clinical Need Toward CURes in Patients With Inherited Predisposition

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2020) 17 (5)
Published: 2020
Articles

CHIPs-A-LOY Loss of Chromosome Y Clusters With CHIP-associated Mutations

Free
Alexander Ambinder, MD, MPH, Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2020) 17 (4)
https://doi.org/10.1182/hem.V17.4.12884901909
Published: 2020
Articles

Can Leuk-warm Be Hot? Heating Up the Debate of Non-canonical Hotspot Spliceosomal Mutations in Myeloid Pathogenesis

Free
Amy DeZern, MD, MHS, Andrew H. Marple, MD, PhD
Journal: The Hematologist
The Hematologist (2020) 17 (3)
https://doi.org/10.1182/hem.V17.3.10321
Published: 2020
Articles

Identification of Malignant Cell Populations Years Before Development of Treatment-related Leukemia in Patients With Myeloma

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2020) 17 (2)
https://doi.org/10.1182/hem.V17.2.10253
Published: 2020
Articles

2019 Brings Biologic Understanding and Hope for Patients With TP53 Mutated Myelodysplastic Syndrome

Free
Amy DeZern, MD, MHS, Theodoros Karantanos, MD, PhD
Journal: The Hematologist
The Hematologist (2019) 17 (1)
https://doi.org/10.1182/hem.V17.1.10133
Published: 2019
Articles

Does Your MDS Treatment Have Mettle? The Utility of Iron Chelation Is Always a Point of Discussion in MDS

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2019) 16 (6)
https://doi.org/10.1182/hem.V16.6.9910
Published: 2019
Articles

Compelling Evidence for Targeted Immunotherapy As Treatment for AML

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2019) 16 (5)
https://doi.org/10.1182/hem.V16.5.9779
Published: 2019
Articles

Compelling Evidence for Targeted Immunotherapy As Treatment for AML

Free
Amanda B. Kagan, MD, Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2019) 16 (5)
Published: 2019
Articles

Should We Utilize Maintenance Therapy Post-Hematopoietic Cell Transplantation in Patients With FLT3/ITD-positive AML?

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2019) 16 (4)
https://doi.org/10.1182/hem.V16.4.9638
Published: 2019
Articles

Thrombocytopenia Post-transplantation: A Clinical Challenge in Need of a Therapy

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2019) 16 (3)
https://doi.org/10.1182/hem.V16.3.9512
Published: 2019
Articles

A New Standard Emerges: Rational Use of Venetoclax to Inhibit BCL-2 Allows Treatment of AML In Older Patients

Free
Amy DeZern, MD, MHS
Journal: The Hematologist
The Hematologist (2019) 16 (2)
https://doi.org/10.1182/hem.V16.2.9382
Published: 2019